The Hybrid-APC in the endoscopic treatment of Barrett's esophagus
Abstract
Background: due to the risk of unsatisfactory evolution of patients with Barrett's esophagus (EB) towards esophageal adenocarcinoma, it is necessary to apply safe and effective techniques that prevent the outcome towards esophageal malignant lesions. The Hybrid-APC (argon plasma coagulation) is one of these techniques that allow stopping the natural history of EB in its initial stage.
Objective: to conduct a review and reflection on the endoscopic treatment of Barrett's esophagus with the Hybrid-APC.
Methods: a search was conducted on Google, PudMed, SciELo regional, SciELo Public Health, National Library of Medicine PudMed engines. The search strategy used the terms: Barrett's esophagus, endoscopic treatment, Hybrid-APC. Extensive documents were evaluated and a summary document of the information collected was developed. The literature search found 20 works related to Barrett's esophagus, ten on endoscopic treatment, and five on specific to the use of Hybrid-APC.
Results: studies reported the effectiveness and security of the ablation with the Hybrid-APC in the endoscopic treatment of Barrett's esophagus with low degree dysplasia, and in the high degree dysplasia and remnant carcinoma in situ, after the endoscopic mucous resection.
Conclusions: the endoscopic treatment of Barrett's esophagus with Hybrid-APC is considered an alternative technique to stop the evolution of this pathology towards adenocarcinoma. This will generate motivation for training and its implementation in a generalized way.
DeCS: BARRETT'S ESOPHAGUS/therapy; ARGÓN PLASMA COAGULATION/methods; GASTROINTESTINAL ENDOSCOPY/methods; ESOPHAGEAL NEOPLASMS/therapy; ENDOSCOPY/methods.
Downloads
References
1. Gould JC, Wendling MR, Oeschlager BK, Mittal SK, Komanduri S, Perry KA et al. Advances in the Diagnosis and Treatment of Barrett´s Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium. J Gastrointest Surg [Internet]. 2017 [citado 5 Feb 2020]; 21(8):1342-1349. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28243981/.
2. Ministerio de Salud Pública. Anuario estadístico de salud 2018 [Internet]. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2019 [citado 05 Feb 2020]. Disponible en: http://bvscuba.sld.cu/anuario-estadistico-de-cuba/.
3. Steele D, Baig KK, Peter S. Evolving screening and surveillance techniques for Barrett´s esophagus. World J Gastroenterol [Internet]. 2019 [citado 05 Feb 2020];25(17):2045-2057. Disponible en: https://www.wjgnet.com/1007-9327/full/v25/i17/2045.htm
4. Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S, et al. ASGE guideline on screening and surveillance of Barrett´s esophagus. Gastrointest endosc [Internet]. 2019 [citado 05 Feb 2020];90(3):335-359. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0016-5107(19)31704-3
5. Omodeo M, Pereyra L, Gómez EJ, Luna P, González R, Fischer C, et al. Tasa de progresión a displasia de alto grado y adenocarcinoma en pacientes con esófago de Barrett durante el seguimiento endoscópico. Acta Gastroenterol Latinoam [Internet]. 2018 [citado 05 Feb 2020];48(2):124-130. Disponible en: http://actagastro.org/tasa-de-progresion-a-displasia-de-alto-grado-y-adenocarcinoma-en-pacientes-con-esofago-de-barrett-durante-el-seguimiento-endoscopico/.
6. Sharma P, Shaheen NJ, Katzka D, Bergman J. AGA Clinical Practice Update on Endoscopic Treatment of Barrett´s esophagus with dysplasia and/or early cancer: Expert review. Gastroenterology [Internet]. 2020 [citado 05 Feb 2020];158(3):760-769. Disponible en: https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2819%2941537-0
7. Alsop BR, Sharma P. Esophageal cáncer. Gastroenterol Clin N Am [Internet]. 2016 [citado 05 Feb 2020];45(3):399-412. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27546839/.
8. Van Laethem JL, Carneiro F, Ducreux M, Messman H, Lordick DH, Ilson WH, et al. The multidisciplinary management of gastro-oesophageal junction tumours. European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona. Dig Liver Dis [Internet]. 2016 [citado 05 Feb 2020];48(11):1283-1289. Disponible en: https://www.dldjournalonline.com/article/S1590-8658(16)30689-2/abstract
9. Alnasser S, Agnihotram R, Martel M, Mayrand S, Franco E. Predictores de la progresión displásica y neoplásica del esófago de Barrett. J Can Chir [Internet]. 2019 [citado 05 Feb 2020];62(2):93-99. Disponible en: https://www.intramed.net/contenidover.asp?contenidoid=94215
10. Sharma P. Diagnostic Testing for Barrett Esophagus. Gastroenterol Hepatol [Internet]. 2020 [citado 05 Feb 2020];16(2):92-94. Disponible en: https://www.gastroenterologyandhepatology.net/archives/february-2020/diagnostic-testing-for-barrett-esophagus/.
11. Shaheen NJ, Falk GW, Iyer PG, Gerson L. ACG Clinical Guideline: Diagnosis and Management of Barrett´s Esophagus. Am J Gastroenterol [Internet]. 2016 [citado 05 Feb 2020];111(1):30-50. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26526079/.
12. Weusten B, Bisschops R, Coron E, Dinis Ribeiro M, Dumonceau JM, Esteban JM, et al. Endoscopic management of Barrett´s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy [Internet]. 2017 [citado 05 Feb 2020];49:191–198. Disponible en: https://www.esge.com/assets/downloads/pdfs/guidelines/2016_s_0042_122140.pdf
13. Fitzgerald RC, Di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett´s oesophagus. Gut [Internet]. 2014 [citado 05 Feb 2020];63:7-42. Disponible en: https://gut.bmj.com/content/63/1/7
14. Singh T, Sanghi V, Thota PN. Current management of Barrett esophagus and esophageal adenocarcinoma. Cleve Clin J Med [Internet]. 2019 [citado 05 Feb 2020];86(11):724-732. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31710585/.
15. Waxman I, González-Haba-Ruiz M, Vázquez-Sequeiros E. Endoscopic diagnosis and therapies for Barrett´s esophagus. A review. Rev Esp Enferm Dig [Internet]. 2014 [citado 05 Feb 2020];106(2):103-119. Disponible en: http://scielo.isciii.es/pdf/diges/v106n2/revision.pdf
16. Martinucci I, Bortoli N, Russo S, Bertani L, Furnari M, Mokrowiecka A, et al. Barrett´s esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther [Internet]. 2016 [citado 05 Feb 2020];7(2):190-206. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848241/.
17. Golger D, Probst A, Messmann H. Barretts esophagus: lessons from recent clinical trials. Ann Gastroenterol [Internet]. 2016 [citado 05 Feb 2020];29:1-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27708506/.
18. Fujii-Lau LL, Cinnor B, Shaheen N, Gaddam S, Komanduri S, Muthusamy VR, et al. Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett´s esophagus: a systematic review and meta-analysis. Endos Inter Open [Internet]. 2017 [citado 05 Feb 2020];5:430-449. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28573176/.
19. Vennalaganti P, Sharma P, Thoguluva Chandrasekar V. Manejo del esófago de Barrett: del tamizaje a los nuevos tratamientos. Rev Gastro Mex [Internet]. 2016 [citado 05 Feb 2020];81(2):91-102. Disponible en: https://medes.com/publication/149319
20. Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, et al. Guidelines for diagnosis and treatment of carcinoma of esophagus. Esophagus [Internet]. 2015 [citado 05 Feb 2020];12:1-30. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297610/.
21. Schölvinck DW, Meulen K, Bergman JJ, Weusten B. Detection of lesions in dysplastic Barrett´s esophagus by community and expert endoscopists. Endoscopy [Internet]. 2017 [citado 05 Feb 2020];49(02):113-120. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27855466/.
22. Seijas Cabrera OR, Brizuela Quintanilla R, Anido Escobar V, Montes de Oca E, Pérez Triana F, García-Menocal JL. Tratamiento endoscópico del Esófago de Barrett. Rev haban cienc méd [Internet]. 2014 [citado 05 Feb 2020];13(2):247-257. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2014000200010&lng=es
23. Ablation of Barrett´s esophagus with Hybrid APC [Internet]. Germany: Erbe Elektromedizin GmbH; 2016 [citado 05 Feb 2020]:[aprox. 8 p.]. Disponible en: https://www.erbe-med.com/erbe/media/Marketingmaterialien/85110-108_ERBE_EN_Barrett_ablation_with_HybridAPC__D083359.pdf
24. Manner H, Neugebauer A, Scharpf M, Braun K, May A, Ell C, et al. The tissue effect of argon-plasma coagulation with prior submucosal injection (Hybrid-APC) versus standard APC: A randomized ex-vivo study. Gastroenterol J [Internet]. 2014 [citado 05 Feb 2020];2(5):383-390. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212496/.
25. Manner H, May A, Kouti I, Pech O, Vieth M, Ell C. Efficacy and safety of Hybrid-APC for the ablation of Barrett´s esophagus. Surg Endosc [Internet]. 2016 [citado 05 Feb 2020];30(4):1364-70. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26104794/.
26. Kashin SV, Kuvaev R, Nadezhin AS, Kraynova EA, Nekhaykova N. The New Hybrid Argon Plasma Coagulation (Hybrid APC) for Endoscopic Ablation of Barrett's Esophagus (BE): the Results of the Pilot Trial. Gastrointest Endosc [Internet]. 2016 [citado 05 Feb 2020];83(suppl 5):AB495. Disponible en: https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.giejournal.org%2Farticle%2FS0016-5107%2816%2900969-X%2Fabstract&rc=0
27. Pech O. Hybrid Argon Plasma Coagulation in Patients with Barrett Esophagus. Gastroenterol Hepatol [Internet]. 2017 [citado 05 Feb 2020];13(10):610-612. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718177/.
28. Kashin S, Vidyaeva N, Kuvaev R, Kraynova E, Manner H. Hybrid-apc for the endoscopic eradication of dysplastic Barrett's esophagus in a low prevalence country: long-term results of the treatment after the onsite training. Endoscopy [Internet]. 2019 [citado 05 Feb 2020];51(4):238. Disponible en: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0039-1681884
29. Nieto J, Casas D. Salvage Hybrid APC after failed radiofrequency ablation and cryotherapy for Barrett´s esophagus. Am J Gastroenterol [Internet]. 2019 [citado 05 Feb 2020];114:544-545. Disponible en: https://journals.lww.com/ajg/Abstract/2019/10001/935_Salvage_Hybrid_APC_After_Failed_Radiofrequency.935.aspx
30. Han J, Shimizu T, Yu A, Fortinsky K, Lee DP, Chang K, et al. Efficacy, Tolerance, and Safety of Hybrid Argon Plasma Coagulation for the Treatment of Barrett´s Esophagus: A U.S. Pilot Study. Am J Gastroenterol [Internet]. 2018 [citado 05 Feb 2020];113:213-214. Disponible en: https://journals.lww.com/ajg/Fulltext/2018/10001/Efficacy,_Tolerance,_and_Safety_of_Hybrid_Argon.371.aspx
Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/
22 julio 2025